Post by British Society for Immunology

A useful review by Anna Szaflarska, Marzena Lenart, Magdalena Rutkowska‑Zapała and Maciej Siedlar (Clinical and Experimental Immunology) revisits the clinical and therapeutic landscape of sIgAD, CVID and THI. It highlights their overlapping biology, diagnostic challenges (especially in childhood), and shared management strategies, while situating emerging options, like stem cell transplantation and targeted therapies, within a shift toward more personalised care. A concise reminder of how heterogeneous these conditions are, and why tailored approaches remain essential. https://vist.ly/584rg #Immunology #PrimaryImmunodeficiency #RareDiseases